CRON

Cronos Group Stock Analysis

AI Rating

Neutral
  • Quality6/10
  • Growth 5/10
  • Momentum 6/10
Cronos Group sales and earnings growth
CRON Growth
Neutral
  • Revenue Y/Y 19.00%
  • EPS Y/Y 0.00%
  • FCF Y/Y -130.08%
Cronos Group gross and profit margin trends
CRON Profitability
Good
  • Gross margin 43.40%
  • EPS margin 27.30%
  • ROIC -2.60%
Cronos Group net debt vs free cash flow
CRON Risk
Great
  • Debt / Equity 0.0
  • Debt / FCF 0.0
  • Interest coverage -0.1

Cronos Group stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Drug Manufacturers - Specialty & Generic stocks ↗